This important result may indicate that metformin can activate OCT to increase metformin’s transport into TME of BRCA in high concentrations and enhance the infiltration of Macrophage M1 into TME to give chance for both metformin itself and Macrophage M1 to attack the tumor cells of BRCA. The gene discussed is PLXNA2; the disease is neoplasm.